reference/28273075

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28273075

Outgoing Links

Predicate	Object
contentType	Evaluation Study\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1262
issn	0300-7995 1473-4877
issueIdentifier	8
pageRange	1253-1262
publicationName	Current Medical Research and Opinion
startingPage	1253
bibliographicCitation	Vergnenegre A, Smit EF, Toy E, Parente B, Schmitz S, Kraaij K, Soldatenkova V, Visseren-Grul C, Zanotti G, Taipale K, Moro-Sibilot D. Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study. Current Medical Research and Opinion. 2012 Jul 05;28(8):1253–62. doi: 10.1185/03007995.2012.703133.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2783a73c160bc2a324b221244da7408d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fc07a8d0ac5cf5609022f3d1b74666b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6776-8610 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f64e46afac736022e060cb1a71452e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edac47b759d2bae893eb793e2759ed90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e274f14feb534ccdef1441aaea822c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33655045f644b6cdb5414156691be0b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b64b7a977c5f9f49445114b94d6b2e9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_473ee9ef73c7639f73efa22748b1850d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf81bedf3f8935cb1814e8ef2cc0338c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d02291617a57bb66707c56db2a88f8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0811eeb9668acfd1993986220818356e
date	2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22697276 https://doi.org/10.1185/03007995.2012.703133
isPartOf	https://portal.issn.org/resource/ISSN/1473-4877 https://portal.issn.org/resource/ISSN/0300-7995 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3218
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017024Q000706 http://id.nlm.nih.gov/mesh/D002289Q000628 http://id.nlm.nih.gov/mesh/D008175Q000628 http://id.nlm.nih.gov/mesh/D008495Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003131Q000379 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D017024Q000379 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008175Q000453 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D002985 http://id.nlm.nih.gov/mesh/D002289Q000453 http://id.nlm.nih.gov/mesh/D007557Q000453 http://id.nlm.nih.gov/mesh/D000465 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D019370 http://id.nlm.nih.gov/mesh/D011364 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010568Q000453 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005060Q000453 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D012383Q000453
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660

Total number of triples: 67.